Search

Your search keyword '"Rydzewski, Andrzej"' showing total 194 results

Search Constraints

Start Over You searched for: Author "Rydzewski, Andrzej" Remove constraint Author: "Rydzewski, Andrzej"
194 results on '"Rydzewski, Andrzej"'

Search Results

1. Long-Term Results from an Open-Label Extension Study of Atacicept for the Treatment of IgA Nephropathy

2. Recovery of dialysis patients with COVID-19: health outcomes 3 months after diagnosis in ERACODA

3. Convalescent plasma treatment is associated with lower mortality and better outcomes in high-risk COVID-19 patients – propensity-score matched case-control study

4. High response rates with single-agent belantamab mafodotin in relapsed systemic AL amyloidosis

5. FRAX prognostic and intervention thresholds in the management of major bone fractures in hemodialysis patients: A two-year prospective multicenter cohort study

7. Real‐world efficacy of single‐agent belantamab mafodotin in relapsed systemic AL amyloidosis

8. Association of obesity with 3-month mortality in kidney failure patients with COVID-19

10. COVID-19 humoral response

12. COVID-19-related mortality in kidney transplant and haemodialysis patients

14. Sex differences in COVID-19 mortality risk in patients on kidney function replacement therapy

15. Safety of intravenous ferric carboxymaltose versus oral iron in patients with nondialysis-dependent CKD: an analysis of the 1-year FIND-CKD trial

16. Clinical, Functional, and Mental Health Outcomes in Kidney Transplant Recipients 3 Months After a Diagnosis of COVID-19

17. Recovery of dialysis patients with COVID-19: health outcomes 3 months after diagnosis in ERACODA.

18. Recovery of dialysis patients with COVID-19:health outcomes 3 months after diagnosis in ERACODA

22. Analysis of 75 consecutive COVID-19 ECMO cases in Warsaw Centre for Extracorporeal Therapies

23. Higher Prevalence of Chronic Kidney Disease in Myelodysplastic Syndromes Patients Compared to Age- Adjusted General Population - Results from the Polish Adult Leukemia Group (PALG) Registry

24. High Responses Rates with Single Agent Belantamab Mafodotin in Relapsed Systemic AL Amyloidosis

26. FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia

37. Clinicopathologic correlations of renal pathology in the adult population of Poland

38. ANCA-associated vasculitis patients treated in Polish intensive care units – retrospective characteristics based on the POLVAS registry

39. Clinical significance of plasminogen activator inhibitor activity in patients with exercise-induced ischemia

42. Przewlekła choroba nerek u bezobjawowych pacjentów cierpiących na ostrą przerywaną porfirię - opis przypadku.

43. Renin-Angiotensin System Blockers and the Risk of COVID-19–Related Mortality in Patients with Kidney Failure

49. Obrzęk szpiku u biorców przeszczepu nerki leczonych inhibitorami kalcyneuryny : opis przypadków

Catalog

Books, media, physical & digital resources